Action Center

Prior Authorization for MAT
Action Alert
March 19, 2019

House Bill 121, sponsored by Rep. Kim Moser, would have increased access to medication-assisted treatment (MAT) as well as prohibited commercial insurers, the Department of Medicaid Services, and Medicaid MCOs from setting requirements or using certain utilization reviews, such as prior authorization, for certain prescription drugs used to treat opioid use disorder. KMA will continue advocating for this important legislation during the interim and expects to see it revisited during the 2020 session.

March 12, 2019

House Bill 121, sponsored by Rep. Kim Moser, would increase access to medication-assisted treatment (MAT) as well as prohibit commercial insurers, the Department of Medicaid Services, and Medicaid MCOs from setting requirements or using certain utilization reviews, such as prior authorization, for certain prescription drugs used to treat opioid use disorder. The bill is still awaiting a hearing by the Senate Banking and Insurance Committee.

Please contact members of the Senate Banking and Insurance Committee and ask them to support House Bill 121.
 
PLEASE CONTACT MEMBERS OF THE
SENATE BANKING & INSURANCE COMMITTEE
AND ASK THEM TO SUPPORT HOUSE BILL 121.


Legislative Message Line: (800) 372-7181

March 5, 2019

House Bill 121, sponsored by Rep. Kim Moser, would increase access to medication-assisted treatment (MAT) as well as prohibit commercial insurers, the Department of Medicaid Services, and Medicaid MCOs from setting requirements or using certain utilization reviews, such as prior authorization, for certain prescription drugs used to treat opioid use disorder. The bill has been in the Senate Banking and Insurance Committee for more than two weeks. As stakeholders attempt to reach compromise on the bill’s final language, KMA is hopeful that the legislation will receive a committee hearing during the upcoming week.

Please contact members of the Senate Banking and Insurance Committee and ask them to support House Bill 121.
 
PLEASE CONTACT MEMBERS OF THE
SENATE BANKING & INSURANCE COMMITTEE
AND ASK THEM TO SUPPORT HOUSE BILL 121.


Legislative Message Line: (800) 372-7181

February 12, 2019

House Bill 121, also sponsored by Rep. Kim Moser, passed favorably from the House Health and Family Services Committee on Feb. 7 and moved on to the full House, where it passed on a 97-0 vote on Feb. 11. HB121 would increase access to medication-assisted treatment (MAT). It would also prohibit commercial insurers, the Department of Medicaid Services, and Medicaid MCOs from setting requirements or using certain utilization reviews, such as prior authorization, for certain prescription drugs used to treat opioid use disorder. HB121, a KMA priority, now proceeds to the Senate for consideration.
 
PLEASE CALL YOUR SENATOR
AND ASK THEM TO
SUPPORT HOUSE BILL 121.


Legislative Message Line: (800) 372-7181
February 5, 2019

Despite a 23 percent decline in opioid prescriptions in Kentucky since 2013, and an increase in the use of the state prescription drug monitoring program, the state's opioid epidemic continues to worsen.  Unfortunately, access to high-quality, evidence-based treatment for opioid use disorder is lacking.  In Kentucky, 89 percent of patients in need of addiction treatment services do not receive it.  The Kentucky Medical Association is urging policymakers to join the Association and other stakeholders, including the American Medical Association and the Kentucky Society of Addiction Medicine, in not simply supporting increased access to treatment, but by taking action to remove barriers to high-quality, evidence-based care.

HB 121 provides a simple, direct, and effective solution.  House Bill 121 will increase access to medication-assisted treatment (MAT) for opioid use disorder, which is proven to save lives. This includes medications such as Methadone, Buprenorphine, or Naltrexone.  House Bill 121 also ends health insurance company practices - such as "prior authorization" - that delays or denies access to MAT for the treatment of opioid use disorder.

HB 121 will be heard in committee on Thursday. 

Please CALL TODAY and leave a message for members of the
House Health and Family Services Committee asking them to
VOTE "YES" on HB 121.

 
Legislative Message Line: (800) 372-7181
 
.
    Subject
    Message Body
    Tweet
    Suggested Message
    Post
    Remaining: 0
  • Hide
    • Please call this number:

      Please do not close this window. You will need to come back to this window to enter your code.
      We just sent an email to ... containing a verification code.

      If you do not see the email within the next five minutes, please ensure you entered the correct email address and check your spam/junk mail folder.
      Enter Your Info